Evidence map›Paper›PMID 28545104›Full record

ArticlePLoS pathogens2017

PknG senses amino acid availability to control metabolism and virulence of Mycobacterium tuberculosis.

Barbara Rieck, Giulia Degiacomi, Michael Zimmermann, Alessandro Cascioferro, Francesca Boldrin, Natalie R Lazar-Adler, Andrew R Bottrill, Fabien le Chevalier, Wafa Frigui, Marco Bellinzoni and 7 more

Abstract read
In one paragraph

Article in PLoS pathogens, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Combating Tuberculosis via Restoring the Host Immune Capacity by TargetingInternational journal of molecular sciences · 2024
    Review
  13. Article
  14. Microbiology spectrum · 2024
    Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Microorganisms · 2022
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Barbara RieckDepartment of Infection, Immunity and Inflammation, University of Leicester, Leicester, United Kingdom.
Giulia DegiacomiDepartment of Molecular Medicine, University of Padua, Padova, Italy.ORCID http://orcid.org/0000-0002-3626-8311
Michael ZimmermannInstitute of Molecular Systems Biology, ETH Zurich, Zurich, Switzerland.
Alessandro CascioferroInstitut Pasteur, Integrated Mycobacterial Pathogenomics Unit, Paris, France.
Francesca BoldrinDepartment of Molecular Medicine, University of Padua, Padova, Italy.
Natalie R Lazar-AdlerCore Biotechnology Services, University of Leicester, Leicester, United Kingdom.ORCID http://orcid.org/0000-0001-5775-7627
Andrew R BottrillCore Biotechnology Services, University of Leicester, Leicester, United Kingdom.ORCID http://orcid.org/0000-0002-5182-3643
Fabien le ChevalierInstitut Pasteur, Integrated Mycobacterial Pathogenomics Unit, Paris, France.ORCID http://orcid.org/0000-0001-5260-682X
Wafa FriguiInstitut Pasteur, Integrated Mycobacterial Pathogenomics Unit, Paris, France.ORCID http://orcid.org/0000-0001-5172-7961
Marco BellinzoniInstitut Pasteur, Unité de Microbiologie Structurale and CNRS-UMR3528, Paris, France.ORCID http://orcid.org/0000-0002-8887-6917
María-Natalia LisaInstitut Pasteur, Unité de Microbiologie Structurale and CNRS-UMR3528, Paris, France.ORCID http://orcid.org/0000-0001-9630-8090
Pedro M AlzariInstitut Pasteur, Unité de Microbiologie Structurale and CNRS-UMR3528, Paris, France.ORCID http://orcid.org/0000-0002-4233-1903
Liem NguyenDepartment of Molecular Biology and Microbiology, Case Western Reserve University School of Medicine, Cleveland, Ohio, United States of America.
Roland BroschInstitut Pasteur, Integrated Mycobacterial Pathogenomics Unit, Paris, France.ORCID http://orcid.org/0000-0003-2587-3863
Uwe SauerInstitute of Molecular Systems Biology, ETH Zurich, Zurich, Switzerland.
Riccardo ManganelliDepartment of Molecular Medicine, University of Padua, Padova, Italy.
Helen M O'HareDepartment of Infection, Immunity and Inflammation, University of Leicester, Leicester, United Kingdom.ORCID http://orcid.org/0000-0002-8666-7433

Funding

Biotechnology and Biological Sciences Research Council BB/H007865/1Medical Research Council MC_PC_15045
6 · The paper itself

Abstract

Sensing and response to changes in nutrient availability are essential for the lifestyle of environmental and pathogenic bacteria. Serine/threonine protein kinase G (PknG) is required for virulence of the human pathogen Mycobacterium tuberculosis, and its putative substrate GarA regulates the tricarboxylic acid cycle in M. tuberculosis and other Actinobacteria by protein-protein binding. We sought to understand the stimuli that lead to phosphorylation of GarA, and the roles of this regulatory system in pathogenic and non-pathogenic bacteria. We discovered that M. tuberculosis lacking garA was severely attenuated in mice and macrophages and furthermore that GarA lacking phosphorylation sites failed to restore the growth of garA deficient M. tuberculosis in macrophages. Additionally we examined the impact of genetic disruption of pknG or garA upon protein phosphorylation, nutrient utilization and the intracellular metabolome. We found that phosphorylation of GarA requires PknG and depends on nutrient availability, with glutamate and aspartate being the main stimuli. Disruption of pknG or garA caused opposing effects on metabolism: a defect in glutamate catabolism or depletion of intracellular glutamate, respectively. Strikingly, disruption of the phosphorylation sites of GarA was sufficient to recapitulate defects caused by pknG deletion. The results suggest that GarA is a cellular target of PknG and the metabolomics data demonstrate that the function of this signaling system is in metabolic regulation. This function in amino acid homeostasis is conserved amongst the Actinobacteria and provides an example of the close relationship between metabolism and virulence.

Indexed as

MetabolomicsMycobacterium tuberculosisAmino AcidsAnimalsAspartic AcidBacterial ProteinsGlutamic AcidHomeostasisMacrophagesMicePhosphorylationProtein Serine-Threonine KinasesTuberculosisVirulenceAmino AcidsAspartic AcidBacterial ProteinsGlutamic Acidprotein kinase G, Mycobacterium tuberculosisProtein Serine-Threonine Kinases

Identifiers

PMID28545104
PMCPMC5448819

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.